PETRONET.NSE logo

PETRONET.NSE
Petronet LNG Ltd.

564
Loading...
Loading...
News
all
press releases
Petronet LNG Launches Postal Ballot, Publishes E-Voting Details for Shareholders
Petronet Lng Limited ( ($IN:PETRONET) ) has shared an announcement. Petronet LNG Limited, a key player in India’s LNG import and regasification sec...
News Placeholder
More News
News Placeholder
Petronet LNG Launches Postal Ballot, Publishes E-Voting Details for Shareholders
Petronet Lng Limited ( ($IN:PETRONET) ) has shared an announcement. Petronet LNG Limited, a key player in India’s LNG import and regasification sec...
News Placeholder
Petronet LNG sees no clarity on Qatar supply for June
India’s largest LNG buyer hasn’t received shipments from Qatar since the Iran war disrupted flows through the Strait of Hormuz, which handled about 60% of India’s LNG flows
News Placeholder
Petronet LNG sees no clarity on Qatar supply for June
India’s largest LNG buyer hasn’t received shipments from Qatar since the Iran war disrupted flows through the Strait of Hormuz, which handled about 60% of India’s LNG flows
News Placeholder
Brief India: Indian Markets Have Made Bottom: Signals and Insights from India VIX and more
In this briefing: Indian Markets Have Made Bottom: Signals and Insights from India VIX Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Q2 Outlook - Asian Equity Markets APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! 1. Indian Markets Have Made Bottom: Signals and Insights from India VIX India VIX hit a 52-week high of 28.91 amid geopolitical tensions. On April 8, it dropped 20% after a ceasefire announcement, while Nifty rose 3.78% to near 24,000 . Historically, seven VIX spikes above 25 led to positive 1-year Nifty returns , averaging 21%. This time, volatility surged globally, indicating a synchronized risk-off phase. The sharp VIX reversal signals a potential market bottom . A sustained Nifty move above 23,500 and VIX holding below 22 would confirm a recovery trend. 2. Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Leading Global Position in Niche Specialty Chemicals: Clean Science and Technology is a leading global manufacturer of functionally critical specialty chemicals, holding a dominant market share in several of its key products like MEHQ, BHA, and Guaiacol.
News Placeholder
Brief India: Indian Markets Have Made Bottom: Signals and Insights from India VIX and more
In this briefing: Indian Markets Have Made Bottom: Signals and Insights from India VIX Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Q2 Outlook - Asian Equity Markets APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! 1. Indian Markets Have Made Bottom: Signals and Insights from India VIX India VIX hit a 52-week high of 28.91 amid geopolitical tensions. On April 8, it dropped 20% after a ceasefire announcement, while Nifty rose 3.78% to near 24,000 . Historically, seven VIX spikes above 25 led to positive 1-year Nifty returns , averaging 21%. This time, volatility surged globally, indicating a synchronized risk-off phase. The sharp VIX reversal signals a potential market bottom . A sustained Nifty move above 23,500 and VIX holding below 22 would confirm a recovery trend. 2. Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Leading Global Position in Niche Specialty Chemicals: Clean Science and Technology is a leading global manufacturer of functionally critical specialty chemicals, holding a dominant market share in several of its key products like MEHQ, BHA, and Guaiacol.
News Placeholder
Brief India: Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 and more
In this briefing: Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Q2 Outlook - Asian Equity Markets APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 1. Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Leading Global Position in Niche Specialty Chemicals: Clean Science and Technology is a leading global manufacturer of functionally critical specialty chemicals, holding a dominant market share in several of its key products like MEHQ, BHA, and Guaiacol. This leadership is built on the back of its proprietary, eco-friendly manufacturing processes. Strong Financial Profile with High Profitability: The company has consistently demonstrated robust financial performance, characterized by high EBITDA margins and a strong balance sheet with minimal debt. This financial strength allows for significant reinvestment in research and development and capacity expansion.
News Placeholder
Brief India: Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 and more
In this briefing: Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Q2 Outlook - Asian Equity Markets APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 1. Primer: Clean Science and Technology (CLEAN IN) - Apr 2026 Leading Global Position in Niche Specialty Chemicals: Clean Science and Technology is a leading global manufacturer of functionally critical specialty chemicals, holding a dominant market share in several of its key products like MEHQ, BHA, and Guaiacol. This leadership is built on the back of its proprietary, eco-friendly manufacturing processes. Strong Financial Profile with High Profitability: The company has consistently demonstrated robust financial performance, characterized by high EBITDA margins and a strong balance sheet with minimal debt. This financial strength allows for significant reinvestment in research and development and capacity expansion.
News Placeholder
Brief India: Q2 Outlook - Asian Equity Markets and more
In this briefing: Q2 Outlook - Asian Equity Markets APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 True Cost of Running an AI Data Centre: A Unit Economics Breakdown 1. Q2 Outlook - Asian Equity Markets We first review at Q1 performance in the major markets we follow The worst may be over in but news flow will drive markets in the short-term We look at foreign positioning and fund flow data to assess risks 2. APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Wuxi XDC partnered with Akari Therapeutics to accelerate IND filing for Akari’s ADC program. Xuanzhu Biopharmaceutical entered licensing agreement with Boston Oncology for upfront and milestone payments of $100M+. Shionogi secured $119M BARDA contract for manufacturing, procurement, and expanded development of Fetroja for biothreat-related infections.
News Placeholder
Brief India: Q2 Outlook - Asian Equity Markets and more
In this briefing: Q2 Outlook - Asian Equity Markets APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 True Cost of Running an AI Data Centre: A Unit Economics Breakdown 1. Q2 Outlook - Asian Equity Markets We first review at Q1 performance in the major markets we follow The worst may be over in but news flow will drive markets in the short-term We look at foreign positioning and fund flow data to assess risks 2. APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Wuxi XDC partnered with Akari Therapeutics to accelerate IND filing for Akari’s ADC program. Xuanzhu Biopharmaceutical entered licensing agreement with Boston Oncology for upfront and milestone payments of $100M+. Shionogi secured $119M BARDA contract for manufacturing, procurement, and expanded development of Fetroja for biothreat-related infections.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available